TGAN — Transphorm Technology Balance Sheet
0.000.00%
- $300.95m
- $293.00m
- $16.51m
Annual balance sheet for Transphorm Technology, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-KT | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 2.88 | 14.7 | 9.5 | 33.4 | 15.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.709 | 0.844 | 1.62 | 2.56 | 4.4 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5.36 | 18.2 | 14.3 | 44.8 | 30.7 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.77 | 1.32 | 1.36 | 1.65 | 10.9 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 10.3 | 22.2 | 18.1 | 48.6 | 44.5 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 20.7 | 26.7 | 27.1 | 5.29 | 21.9 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 46.9 | 42.1 | 43.2 | 17.3 | 24.8 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -36.6 | -19.9 | -25.1 | 31.4 | 19.6 |
| Total Liabilities & Shareholders' Equity | 10.3 | 22.2 | 18.1 | 48.6 | 44.5 |
| Total Common Shares Outstanding |